A variety of low molecular weight, guanidino-containing molecules capable of acting as MC4-R agonists are provided. The compounds are useful in treating MC4-R mediated diseases. The compounds have the structure IA, IB, or IC where the values of the variable are defined herein.

 
Web www.patentalert.com

< Dihydrobenzofuran derivatives and uses thereof

< Novel quinoxalinone norepinephrine reuptake inhibitors for the treatment of central nervous system disorders

> Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders

> Method for decreasing opioid metabolism
~ 00237